Skip to main content
KESTRA MEDICAL TECHNOLOGIES, LTD. logo

KESTRA MEDICAL TECHNOLOGIES, LTD. — Investor Relations & Filings

Ticker · KMTS ISIN · BMG524411052 US Manufacturing
Open in API
Filings indexed 92 across all filing types
Latest filing 2026-04-01 Capital/Financing Update
Country US United States of America
Listing US KMTS

About KESTRA MEDICAL TECHNOLOGIES, LTD.

https://kestramedical.com/

Kestra Medical Technologies is a medical device and digital healthcare company focused on protecting patients from Sudden Cardiac Arrest (SCA). The company develops the ASSURE® Cardiac Recovery System, a comprehensive solution featuring a Wearable Cardioverter Defibrillator (WCD). This system provides continuous monitoring of a patient's heart rhythm, autonomous detection of life-threatening arrhythmias, and delivers defibrillation therapy when necessary. The ASSURE platform is supported by the Kestra CareStation™, a remote patient data platform for clinicians, and a dedicated patient application designed to enhance engagement and compliance. Kestra's technology is intended for patients at elevated risk for SCA, such as those with heart failure or low left ventricular ejection fraction.

Recent filings

Filing Released Lang Actions
S-3ASR - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is a registration statement used for securities offerings under the Securities Act of 1933. It includes a prospectus describing the offering of common shares, details about the company, risk factors, and other legal and financial information related to the securities offering. This type of filing is related to capital raising activities and financing updates rather than financial performance reports, management changes, or other categories. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2026-04-01 English
144 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Subject)
Regulatory Filings
2026-03-17 English
8-K - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or updates. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release announcing financial results for the fiscal quarter ended January 31, 2026. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes a press release as an exhibit. The length is 3645 characters, which is relatively short and consistent with a current report filing. According to the rules, a Form 8-K announcing quarterly financial results and including a press release is classified as an Earnings Release (ER) because it is the initial announcement of quarterly financial results with key highlights only, not a full interim report (IR).
2026-03-17 English
4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
Director's Dealing
2026-02-19 English
SCHEDULE 13G Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.